BerandaCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
$173,89
Setelah Jam Perdagangan Normal:(0,00%)0,00
$173,89
Tutup: 2 Apr, 16.01.39 GMT-4 · USD · NYSE · Pernyataan Penyangkalan
Tutup sebelumnya
$174,90
Rentang hari
$170,52 - $179,83
Rentang tahun
$91,86 - $228,88
Kapitalisasi pasar
8,58Â M USD
Volume Rata-Rata
1,01Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NYSE
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 994,23Â jt | -0,83% |
Biaya operasional | 284,04Â jt | 21,15% |
Penghasilan bersih | -276,56Â jt | -28,93% |
Margin laba bersih | -27,82 | -30,06% |
Penghasilan per saham | 2,39 | -10,15% |
EBITDA | 169,61Â jt | 12,90% |
Tarif pajak efektif | 6,06% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 213,77Â jt | 9,85% |
Total aset | 7,14Â M | -5,22% |
Total liabilitas | 3,92Â M | -2,39% |
Total ekuitas | 3,21 M | — |
Saham yang beredar | 49,23 jt | — |
Harga terhadap nilai buku | 2,72 | — |
Tingkat pengembalian aset | 1,53% | — |
Tingkat pengembalian modal | 1,88% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -276,56Â jt | -28,93% |
Kas dari operasi | 147,52Â jt | -7,43% |
Kas dari investasi | -92,81Â jt | -21,95% |
Kas dari pembiayaan | -51,86Â jt | 31,65% |
Perubahan kas bersih | 6,78Â jt | 211,65% |
Arus kas bebas | 98,35Â jt | 112,34% |
Tentang
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
Didirikan
1947
Kantor pusat
Situs
Karyawan
19.000